Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(7 sites)

United States

Study Site, Walnut Creek, California

Study Site, St Louis, Missouri

Canada

Study Site, Edmonton

United Kingdom

Study Site, Cambridge

Study Site, Leicester